Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG, Teixeira JM, Dunaif A, Urbanek M.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2862-2872. doi: 10.1210/jc.2017-00612.

2.

Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.

Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.

Clin Endocrinol (Oxf). 2014 Dec;81(6):899-906. doi: 10.1111/cen.12557. Epub 2014 Sep 1.

PMID:
25040369
3.

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.

Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14.

PMID:
23321213
4.

A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.

Kevenaar ME, Laven JS, Fong SL, Uitterlinden AG, de Jong FH, Themmen AP, Visser JA.

J Clin Endocrinol Metab. 2008 Apr;93(4):1310-6. doi: 10.1210/jc.2007-2205. Epub 2008 Jan 29.

PMID:
18230658
5.
6.

Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.

Zheng MX, Li Y, Hu R, Wang FM, Zhang XM, Guan B.

J Assist Reprod Genet. 2016 Feb;33(2):199-205. doi: 10.1007/s10815-015-0641-9. Epub 2016 Jan 6.

7.

Dysregulation of the Anti-Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome.

Pierre A, Taieb J, Giton F, Grynberg M, Touleimat S, El Hachem H, Fanchin R, Monniaux D, Cohen-Tannoudji J, di Clemente N, Racine C.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3970-3978. doi: 10.1210/jc.2017-00308.

PMID:
28938480
8.

[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].

Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.

Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23. Bulgarian.

PMID:
24294740
9.

Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.

Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.

J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):288-97. doi: 10.4274/jcrpe.3253. Epub 2016 Apr 29.

10.

[Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].

Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.

Akush Ginekol (Sofiia). 2014;53(5):22-7. Bulgarian.

PMID:
25558667
11.

Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.

Georgopoulos NA, Karagiannidou E, Koika V, Roupas ND, Armeni A, Marioli D, Papadakis E, Welt CK, Panidis D.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1866-70. doi: 10.1210/jc.2013-2458. Epub 2013 Aug 22.

12.

Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.

Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P.

Clin Endocrinol (Oxf). 2015 Jul;83(1):98-104. doi: 10.1111/cen.12687. Epub 2015 Feb 3.

PMID:
25440474
13.
14.

Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.

Bradbury RA, Lee P, Smith HC.

Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):552-557. doi: 10.1111/ajo.12647. Epub 2017 Jun 9.

PMID:
28597496
15.

Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.

Gorsic LK, Dapas M, Legro RS, Hayes MG, Urbanek M.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2855-2874. doi: 10.1210/jc.2018-02178.

PMID:
30786001
16.

The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.

Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.

Hum Reprod. 2015 Aug;30(8):1927-33. doi: 10.1093/humrep/dev131. Epub 2015 Jun 4.

PMID:
26048913
17.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

PMID:
15802325
18.

The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.

Bungum L, Franssohn F, Bungum M, Humaidan P, Giwercman A.

PLoS One. 2013 Sep 4;8(9):e68223. doi: 10.1371/journal.pone.0068223. eCollection 2013.

19.

The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.

Qi X, Pang Y, Qiao J.

Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:82-7. doi: 10.1016/j.ejogrb.2016.01.029. Epub 2016 Feb 10. Review.

PMID:
26914398
20.

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.

Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, Dewailly D, Catteau-Jonard S, Sundström-Poromaa I, Piltonen TT, Dal Bello F, Medana C, Prevot V, Clasadonte J, Giacobini P.

Nat Med. 2018 Jun;24(6):834-846. doi: 10.1038/s41591-018-0035-5. Epub 2018 May 14.

Supplemental Content

Support Center